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TASOR is a pseudo-PARP that directs HUSH
complex assembly and epigenetic transposon
control
Christopher H. Douse 1,4,9, Iva A. Tchasovnikarova2,5,9, Richard T. Timms 2,9, Anna V. Protasio 2,6,
Marta Seczynska2, Daniil M. Prigozhin 1,7, Anna Albecka1,2,8, Jane Wagstaff3, James C. Williamson2,
Stefan M. V. Freund3, Paul J. Lehner 2✉ & Yorgo Modis 1,2✉
The HUSH complex represses retroviruses, transposons and genes to maintain the integrity
of vertebrate genomes. HUSH regulates deposition of the epigenetic mark H3K9me3, but
how its three core subunits — TASOR, MPP8 and Periphilin — contribute to assembly and
targeting of the complex remains unknown. Here, we define the biochemical basis of HUSH
assembly and find that its modular architecture resembles the yeast RNA-induced tran-
scriptional silencing complex. TASOR, the central HUSH subunit, associates with RNA pro-
cessing components. TASOR is required for H3K9me3 deposition over LINE-1 repeats and
repetitive exons in transcribed genes. In the context of previous studies, this suggests that an
RNA intermediate is important for HUSH activity. We dissect the TASOR and MPP8 domains
necessary for transgene repression. Structure-function analyses reveal TASOR bears a
catalytically-inactive PARP domain necessary for targeted H3K9me3 deposition. We con-
clude that TASOR is a multifunctional pseudo-PARP that directs HUSH assembly and epi-
genetic regulation of repetitive genomic targets.
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Post-translational modification of histones and other chro-matin proteins is a central mechanism by which eukaryoticcells regulate chromatin architecture and tune the dynamics
of DNA-templated processes. One conserved example is tri-
methylation of histone H3 lysine 9 (H3K9me3), an epigenetic
mark typically associated with low levels of transcription1.
H3K9me3 marks repetitive regions of eukaryotic chromosomes
where it presents a binding site for heterochromatin protein 1
(HP1)2. HP1 undergoes liquid-liquid phase separation to form a
chromatin compartment that somehow excludes RNA poly-
merase from the DNA3. However, H3K9me3 is also present in
transcriptionally-active euchromatin4 — for example, over the
bodies of certain protein-coding genes5. The mark is, therefore,
central in maintaining genome stability and controlling tran-
scriptional programs. In mammals, its importance at an orga-
nismal level is underlined by recent observations that dynamic
regulation of H3K9me3 — catalyzed by multiple lysine N-
methyltransferases — is critical for murine development6.
Genetic experiments studying position-effect variegation
(PEV) in model organisms have identified much of the machinery
involved in the formation of H3K9me3 domains7. Such position
effects refer to the influence of local chromatin environment on
gene expression. Forward genetic screens for mutations disrupt-
ing PEV in Drosophila revealed conserved factors required for
heterochromatin formation, including HP1 itself8. Analogously, a
mutagenic screen in a mouse line with a transgene reporter dis-
playing variegated expression identified numerous epigenetic
regulators, the ‘Modifiers of murine metastable epialleles’
(Mommes), several of which are specific to mammals9,10. A for-
ward genetic screen that we conducted previously with an inte-
grating lentiviral reporter identified the human silencing hub
(HUSH) as a novel regulator of PEV in human cells11. HUSH is a
complex of three proteins: transgene activation suppressor
(TASOR), M-phase phosphoprotein 8 (MPP8), and Periphilin
(PPHLN1, isoform 2). The activity of TASOR is critical in early
development: the homozygous mutation L130P, at a conserved
leucine in mouse TASOR (identified as MommeD6), is lethal in
embryos before the completion of gastrulation12. The HUSH
complex recruits the H3K9 methyltransferase SET domain
bifurcated 1 (SETDB1) to deposit H3K9me3 (ref. 11) and the
ATPase MORC2 to compact chromatin13,14. HUSH is a
vertebrate-specific chromatin regulator that represses both exo-
genous and endogenous genetic elements. As well as targeting
integrating lentiviruses, HUSH targets full-length tran-
scriptionally-active retrotransposons including LINE-1s15,16, and
cell-type specific genes such as zinc finger transcription factors
(ZNFs)11,14,15. HUSH is also recruited, via the DNA-binding
protein NP220, to repress expression of unintegrated murine
leukemia virus17. The critical role of HUSH in antiretroviral
immunity is highlighted by findings that primate lentiviral
accessory proteins Vpr and Vpx target HUSH complex proteins
for proteasome-mediated degradation18–20.
In the current model of HUSH-mediated repression, HUSH
regulates both reading and writing of H3K9me3 (ref. 14). The
MPP8 chromodomain binds K9-trimethylated H3 tail peptide21
and H3-like mimic sequences found in other proteins, including
ATF7IP, the nuclear chaperone of SETDB1 (ref. 22). While these
data suggest that MPP8 binding to methylated ATF7IP recruits
SETDB1 to spread H3K9me3 over HUSH targets23, a read-write
mechanism for H3K9me3 spreading involving MPP8 and ATF7IP/
SETDB1 must be too simplistic: TASOR and Periphilin are both
essential for HUSH-dependent lentiviral reporter repression, and
the MPP8 chromodomain is required for establishment but not
maintenance of repression11. Furthermore, HUSH targets are
enriched within transcriptionally-active chromatin15,16, in contrast
to classical heterochromatin regulators. Hence, key unanswered
questions are: how TASOR and Periphilin contribute to HUSH
targeting and repression; how H3K9 methylation by SETDB1 is
regulated; and whether there are distinct mechanisms to recruit
SETDB1 methyltransferase activity to HUSH loci, for example, at
different stages of development.
Here we report multiscale biochemical and functional analyses
of TASOR that provide new mechanistic insights into how HUSH
assembles and regulates its targets. We report on the role of
Periphilin elsewhere24. TASOR is a 1670-amino acid nuclear
protein lacking functional annotations. At the molecular level
TASOR remains poorly characterized, apart from its identifica-
tion as an mRNA binding protein25,26. Here we show that
TASOR is the central assembly platform of HUSH, providing
binding sites for MPP8 and Periphilin. Targeted epigenomic
profiling experiments support the model that TASOR binds and
regulates H3K9me3, specifically over LINE-1 repeats and repeti-
tive exons of transcribed genes. Analysis of HUSH domain
organization reveals striking homology with the yeast RNA-
induced transcriptional silencing (RITS) complex, and in a pro-
teomic screen, we find TASOR associates with RNA processing
components. Together with observations that transgene tran-
scription enhances HUSH binding15, these data suggest that an
RNA intermediate may be important for HUSH activity. Our
cellular assays map the specific subdomains of TASOR and MPP8
necessary for HUSH assembly and transgene repression. Struc-
tural and biochemical studies reveal that TASOR contains a
catalytically inactive poly-ADP ribose polymerase (PARP)
domain that is dispensable for assembly and chromatin targeting
but critical for epigenetic regulation of target elements. We find
that this activity relies on an extended, dynamic loop that is
unique in the PARP family. Our data demonstrate TASOR is a
pseudo-PARP that governs both HUSH assembly and H3K9me3
deposition over repetitive genomic targets.
Results
TASOR regulates H3K9me3 over L1Ps and repetitive exons.
We originally identified HUSH as a repressor of lentiviral
transgenes11,14. Chromatin immunoprecipitation sequencing
(ChIP-seq) showed that HUSH also targets endogenous genes
and transposable elements14–16. Notably, transcription promotes
target binding by the HUSH subunit MPP8 (ref. 15), and HUSH
loci were found in transcriptionally-active euchromatic regions as
defined by epigenetic marks15,16 and sensitivity to sonication4.
These results highlight that H3K9me3 is not restricted to het-
erochromatin and suggest that sonication of cross-linked chro-
matin in ChIP protocols could influence analysis of HUSH
regulation. TASOR ChIP-seq also displayed low sensitivity15. For
these reasons, we applied orthogonal and targeted strategies for
TASOR epigenomic profiling, CUT&RUN27 and CUT&Tag28.
CUT&RUN profiling of H3K9me3 in the presence and absence
of TASOR identified 393 TASOR-regulated loci with high
resolution and sensitivity (Fig. 1a, b and Supplementary Fig. 1a).
The proportion of global H3K9me3 regulated by HUSH— approxi-
mately 1%— was comparable to that determined by ChIP-seq11,15.
We observed a strong association with LINE-1 repeats (L1s) in our
analysis. Of all the transposable element classes overlapped by
TASOR-regulated sites, 86.1% corresponded to L1s of which the
majority were primate-specific L1Ps (Fig. 1c). TASOR CUT&RUN
was unsuccessful, perhaps due to TASOR’s size and poor solubility,
but CUT&Tag gave comparable signal to ChIP-seq with an
order of magnitude lower sequencing depth (Fig. 1a, b). We found
that the strongest TASOR ChIP and CUT&Tag peaks were co-
occupied by H3K9me3, consistent with the model that TASOR
binds chromatin via MPP8 (Fig. 1b and Supplementary Fig. 1b).
Secondary H3K9me3-independent association was also observed at
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a handful of sites by CUT&Tag (Supplementary Fig. 1c). The
resolution afforded by targeted methods enabled boundaries of
TASOR binding and associated H3K9me3 deposition to be
mapped with precision, revealing that this often coincides with
boundaries of L1P sequences (Fig. 1a and Supplementary Fig. 1b).
Although most HUSH loci contain H3K9me3, other epigenetic
marks likely contribute to HUSH complex genome association.
Indeed, H3K9me3 contributes to multiple chromatin states, partly
in combination with other histone modifications, which we do not
investigate here. For example, local acetylation patterns may
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provide an additional selectivity filter for HUSH targeting15 and
SETDB1 methyltransferase activity29.
Intronic L1Ps account for most but not all TASOR-regulated
H3K9me3 peaks that overlap with genes. ZNF (zinc finger) genes
are significantly enriched (P < 2.2 × 10−16, Fisher exact test),
consistent with other data sets11,15. TASOR-regulated H3K9me3
over ZNFs predominantly covers their 3’ exons, which encode
repetitive and rapidly-evolving zinc finger arrays5,30. Inspection
of other non-L1 targets suggested that TASOR-dependent
H3K9me3 deposition may be found over exons encoding
repetitive polypeptides irrespective of gene organization (e.g.,
MUC16 exon 3, BRCA2 exon 11, C2orf16 exon 1, AHNAK exon 5,
CELSR3 exon 1) (Fig. 1a and Supplementary Fig. 1d). Repetitive
or rapidly-evolving genes are sources of recombination and
genome damage5,31, a potential shared by L1Ps. Together, these
observations suggest that HUSH-dependent H3K9me3 deposition
and chromatin compaction could have a genome protective
function alongside its established repressive function.
TASOR binds transcribed genes and RNA processing
machinery. Retroviral and LINE-1 HUSH targets pose a threat to
the genome by replication through an RNA intermediate.
Induced LINE-1 transcription promoted MPP8 genome binding
in K562 cells15 and a subset of HUSH-bound genes were found to
be regulated in a tissue-specific manner15,16. According to rea-
nalysis of RNA-seq data14, the median expression of genes
overlapping TASOR-regulated sites (RPKM= 7.52, n= 228) is
comparable to that of all other genes (RPKM= 7.71, n= 14,211)
(Fig. 1d). Closer examination supports an association between
transcription and H3K9me3 deposition through HUSH. For
example, MUC16 is expressed in HeLa but not K562 cells15 and is
only H3K9me3-marked in a TASOR-dependent manner in HeLa
cells. BRCA2 is expressed in HeLa and K562 and is HUSH-
modified in both lines15 (Fig. 1a and Supplementary Fig. 1d). Our
data support a model in which transcription of LINE-1s or other
repetitive exons correlates with TASOR binding and H3K9me3
deposition over the element.
To investigate associations made by TASOR on chromatin, we
performed proximity-dependent labeling (BioID) using BirA-tagged
TASOR in TASOR knockout (KO) cells (Fig. 1e and Supplementary
Data 1). Using this approach, we identified peptides from TASOR,
MPP8, Periphilin and 10 other chromatin-associated proteins.
Among our top hits were matrin-type zinc finger proteins
ZNF318 and ZNF638 (NP220). Although NP220 is known to
recruit HUSH to unintegrated murine retroviral DNA17, our data
predict additional roles for this interaction in the absence of
infection. We also detected RPRD2, a regulator of RNA Polymerase
II previously identified alongside TASOR as a repressor of LINE-
1s15 and HIV32. HUSH effectors MORC2 and the SETDB1/ATF7IP
complex were absent from the list, suggesting that these fac-
tors interact with HUSH transiently and possibly indirectly (e.g.,
through chromatin). Also absent were proteins usually associated
with transcriptionally-inert heterochromatin, reinforcing the model
that HUSH resides at a subset of H3K9me3-marked sites. 11 of the
14 proteins we identified are annotated RNA-binding proteins.
Several proteins identified (e.g., CCNK, MED19, RPRD2, FIP1L1,
PPP1R10, and TOX4) have been associated with regulating mRNA
processing or RNA polymerase II activity. Association with RNA
processing machinery is consistent with observations that HUSH
binds and regulates transcriptionally-active genomic targets, together
with TASOR’s annotation as an mRNA-interacting protein25,26.
HUSH resembles the yeast RITS complex. Despite its important
roles in antiviral defense and vertebrate development, TASOR
lacks functional annotations in its 1670-residue sequence apart
from a ‘domain of unknown function’ (DUF3715, residues
106–332). Disorder33 and structural homology34,35 prediction on
the primary sequence of TASOR identified four additional
putative domains (Fig. 1f and Supplementary Fig. 2a, b). A Spen
paralog and ortholog C-terminal (SPOC) beta barrel domain
(residues 350–505) is predicted to lie adjacent to DUF3715, while
no structural homology was identified for the third ordered
region (referred to as DomI, residues 525–633). Residues 1233-
1466 exhibit homology to the DomII and PIN domains of the S.
pombe protein Chp1 (Supplementary Fig. 2a). Intriguingly, Chp1
also contains a SPOC domain (Supplementary Fig. 2b) and, like
MPP8, an H3K9me3-binding chromodomain. Furthermore, the
Chp1 binding partner Tas3 is a small protein that resembles
Periphilin (Fig. 1f).
Together Chp1 and Tas3 form the core structure of the yeast
RNA-induced transcriptional silencing (RITS) complex36. The
striking resemblance between the domain organization of RITS
(Chp1-Tas3) to that of HUSH (Fig. 1f) is particularly notable
given the functional similarities between the two complexes. In
yeast, Tas3 self-associates through C-terminal helical repeats to
spread heterochromatic gene silencing37. Periphilin self-associa-
tion — through disordered and C-terminal helical regions — is
likewise required for HUSH repression in human cells24. RITS
targets repetitive sequences in centromeres and telomeres,
and — as predicted for HUSH (Fig. 1g) — mediates deposition
of repressive H3K9me3 over repeat elements in response to
transcription36,38.
Mapping regions in TASOR and MPP8 required for HUSH
activity. Next we assessed which TASOR and MPP8 domains are
required for HUSH transgene repression. We first generated a
panel of TASOR truncation mutants (Supplementary Fig. 3a)
and performed genetic complementation assays in TASOR
knockout cells harboring a de-repressed GFP lentiviral transgene
(Fig. 2a). Upon expression of full-length TASOR, HUSH func-
tion was restored and the reporter was repressed. However,
TASOR deletion mutants lacking the DUF3715, SPOC, or DomI
domains were non-functional. A variant lacking the DomII/PIN
domains (deletion of residues 1233–1670) complemented the
Fig. 1 HUSH activities and domain structures resemble the RITS complex. a Genome browser snapshots of TASOR binding and regulation of H3K9me3.
Shown are CUT&RUN H3K9me3 tracks in TASOR-positive and TASOR-negative HeLa cells (green); CUT&Tag and ChIP TASOR tracks in TASOR-positive
(purple) and TASOR-negative cells; and an IgG control for each technique from control cells (gray). b Heatmaps of the signal from indicated experiments
and replicates across 393 TASOR-regulated loci (rows). The sequencing depth of CUT&Tag TASOR experiments was ~4M reads, compared with ~55M
reads for ChIP-seq. c Overlaps of 393 TASOR-regulated H3K9me3 peaks with different repeat classes. Since these peaks extend over several kilobases
(mean length 6369 bp), several covered more than one annotated repeat. d Coding genes overlapping with TASOR-regulated H3K9me3 peaks were
plotted (red dots) on a scatterplot showing gene transcript levels. Raw data were processed from triplicate RNA-seq data on wild-type HeLa cells, mapped
to hg38 (ref. 14). RPKM, reads per kilobase per million mapped reads. e TASOR BioID hits. HUSH subunits are marked in bold. Control refers to TASOR
knockout cells treated with biotin but not expressing BirA-tagged TASOR. f Predicted domain architecture of Homo sapiens HUSH subunits, showing
similarity with Schizosaccharomyces pombe Chp1 and Tas3. DUF, domain of unknown function. SPOC, Spen ortholog C-terminal. PIN, PilT N-terminus. CD,
chromodomain. HUSH, human silencing hub. RITS, RNA-induced transcriptional silencing complex. g Schematic model of HUSH repression.
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knockout, indicating that this C-terminal region is not required
for transgene repression under the conditions tested. We note
that DomII/PIN is nonetheless highly conserved in TASOR
orthologues, and these domains may therefore play functional
roles not captured by our assay. Indeed, the PIN domain of Chp1
was required for repression by RITS at subtelomeric but not
centromeric repeats36. Finally, a variant with additional C-
terminal truncation— TASOR(1–1085)— retained function, but
TASOR(1–1000) did not.
The domain structure of MPP8 is comparatively simple: an N-
terminal chromodomain separated from C-terminal ankyrin
(helix-loop-helix) repeats by a linker. Surprisingly, we previously
found the chromodomain to be dispensable for the maintenance
of HUSH function, although a mutation that inhibits H3K9me3
binding delayed re-establishment of reporter repression11.
Extending this analysis of MPP8, we found that the first 499
amino acids could be removed without further impairing HUSH
function. However, deletion of an additional 60 residues or the C-
terminal ankyrin repeats did abolish HUSH function (Fig. 2b and
Supplementary Fig. 3b). We conclude that the DUF3715, SPOC,
and DomI domains of TASOR, along with its central linker, are
required to maintain transgene repression by HUSH, but the
DomII/PIN and C-terminus are dispensable. The C-terminal
portion (500–860) of MPP8, which contains the predicted
ankyrin repeats, is likewise required.
TASOR lies at the heart of the HUSH complex. TASOR
domains essential for HUSH function could (i) mediate HUSH
complex formation through interactions with MPP8 and Per-
iphilin or (ii) have biological activities necessary for repression (or
recruit effector proteins with these activities). We first considered
the overall role of TASOR in HUSH assembly. Starting from a cell
line lacking all three HUSH subunits11, we re-expressed subunits
in pairwise combinations and examined their interactions
through reciprocal co-immunoprecipitation (co-IP) (Fig. 3a).
MPP8 and Periphilin precipitated with TASOR but no binding
was detected between MPP8 and Periphilin without TASOR. We
conclude that TASOR lies at the heart of the core HUSH
complex.
To map binding sites, we performed co-IP of endogenous MPP8
with tagged TASOR truncation variants or vice versa. TASOR
DomI was required for MPP8 binding regardless of which protein
was immunoprecipitated (Fig. 3b). The adjoining SPOC domain
was dispensable for MPP8 binding in cells, which was unexpected
since SPOC domains from other transcriptional regulators like yeast
Chp1 form stabilizing protein–protein interactions through an
exposed hydrophobic patch36,39. Attempts to isolate recombinant
TASOR SPOC or DomI domains, or DomI-MPP8 complexes,
resulted in poor yields of soluble protein. However, we were able to
purify a stable, 1:1 TASOR-MPP8 complex following recombinant
co-expression of a tandem TASOR SPOC-DomI construct (residues
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first 499 residues are dispensable. Ticks and crosses indicate functionality in this assay.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18761-6 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4940 | https://doi.org/10.1038/s41467-020-18761-6 | www.nature.com/naturecommunications 5
helices
CD Ankyrin repeats
DUF3715 SPOC DomI DomII PIN
Ser rich
525 633
500 560
1000 1085
285 374
d
b
250
150
kDa M
oc
k
+ 
ΔD
UF
+ 
ΔD
UF
+ 
1–
50
5
+ 
1–
10
00
+ 
1–
80
0
+ 
1–
63
6
+ 
ΔD
om
l
+ 
ΔD
/S
/D
om
l
+ 
ΔD
UF
+ 
1–
50
5
+ 
1–
10
00
+ 
1–
80
0
+ 
1–
63
6
+ 
ΔD
om
l
+ 
ΔD
/S
/D
om
l
+ 
ΔD
UF
+ 
1–
50
5
+ 
1–
10
00
+ 
1–
80
0
+ 
1–
63
6
+ 
ΔD
om
l
+ 
ΔD
/S
/D
om
l
+ 
1–
10
00
+ 
1–
10
85
+ 
ΔD
om
l
+ 
ΔS
PO
C
+ 
Fu
ll-l
en
gt
h
M
oc
k
+ 
ΔD
UF
+ 
1–
10
00
+ 
1–
10
85
+ 
ΔD
om
l
+ 
ΔS
PO
C
+ 
Fu
ll-l
en
gt
h
M
oc
k
+ 
ΔD
UF
+ 
1–
10
00
+ 
1–
10
85
+ 
ΔD
om
l
+ 
ΔS
PO
C
+ 
Fu
ll-l
en
gt
h
Inputs
IB: mCherry (TASOR) IB: MPP8
150
100
kDa
IP: mCherry (TASOR)
250
150
kDa
IP: MPP8
IB: mCherry (TASOR)
IB: mCherry (TASOR)
75
kDa
100
150
250
Inputs IP: PPHLN1
IB: mCherry (TASOR) IB: MPP8
kDa
100
150
IP: mCherry (TASOR)
75
kDa
100
150
250
a
Inputs
100
50
250
kDa + 
TA
SO
R
 +
 M
PP
8
+ 
TA
SO
R
 +
 P
PH
LN
1
+ 
M
PP
8 
+ 
PP
H
LN
1
IP
: T
AS
O
R
IP
: T
AS
O
R
IP
: I
gG
IP
: I
gG
IP
: I
gG
IP
: M
PP
8
IP
: M
PP
8
IP
: V
5
IP
: V
5
150
TASOR
+ V5-PPHLN1
MPP8
+ V5-PPHLN1
HUSH triple knockout clone + subunit pairs
TASOR
+ MPP8
IB:
MPP8
IB: V5
(PPHLN1)
IB:
TASOR
e
HUSH complex interaction sites
TASOR
PPHLN
MPP8
Binary interaction detected?
TASOR - MPP8
MPP8 - TASOR
TASOR - PPHLN
PPHLN - TASOR
MPP8 - PPHLN
PPHLN - MPP8
0
25
50
75
100
125
150
0
0.25
0.5
0.75
1
10 15 20 25
Elution volume (ml)
U
V
 (
A
U
)
M
o
le
cu
la
r 
m
as
s 
(k
D
a)
TASOR-MPP8 complex: size-exclusion chromatography-multiangle light scattering (SEC-MALS)
Theoretical
MW (1:1): 72 kDa
MW (expt): 69 kDa
32 -
25 -
22 -
17 -
46 -
58 -
80 -
100 -
135 -
190 -
245 -
kDa
Coomassie blue
SPOC DomI
860
Ankyrin repeats
528
633354
TASOR
MPP8
c
TASOR-PPHLN: genetic reconstitution of TASOR KO cells with mCherry-TASOR constructs
TASOR-MPP8: genetic reconstitution of TASOR KO cells with mCherry-TASOR constructs
SDS-PAGE
TA
SO
R 
SP
OC
-D
om
l
M
PP
8 
C-
te
rm
TASOR
TASOR
TASOR
PPHLN
PPHLN
MPP8 PPHLN
MPP8
MPP8
Fig. 3 TASOR lies at the heart of the HUSH complex. a TASOR interacts separately with MPP8 and Periphilin to mediate assembly of the HUSH complex.
Pairwise combinations of HUSH subunits were exogenously expressed in HUSH triple KO cells, and interactions detected by co-immunoprecipitation (co-
IP) followed by immunoblot. b TASOR DomI mediates the interaction with MPP8. The indicated TASOR truncation mutants were exogenously expressed in
TASOR KO cells and their association with endogenous MPP8 assessed by co-IP. c SEC-MALS of recombinant TASOR(354–633)-MPP8(528–860)
complex (theoretical MW, 72 kDa for a 1:1 complex) with representative SDS-PAGE gel of SEC peak fractions (inset). d The central linker of TASOR
mediates the interaction with Periphilin. e Summary of core HUSH interaction sites.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18761-6
6 NATURE COMMUNICATIONS |         (2020) 11:4940 | https://doi.org/10.1038/s41467-020-18761-6 | www.nature.com/naturecommunications
354–633) and the MPP8 C-terminus (residues 528–860) (Fig. 3c).
Together these data support a binding mode in which the TASOR
SPOC domain stabilizes DomI and that the interaction with MPP8
occurs through a hydrophobic interface. Since MPP8(500–860) is
functional but MPP8(560-860) is non-functional (Fig. 2b), our data
suggest that the minimal TASOR binding site lies between MPP8
residues 500–560.
To assess the TASOR–Periphilin interaction, we immunopreci-
pitated endogenous Periphilin and blotted for mCherry-tagged
TASOR constructs. Periphilin pulled down TASOR mutants lacking
the DUF3715, SPOC, and DomI domains, but not TASOR(1–1000)
or TASOR variants with longer C-terminal truncations (Fig. 3d).
We noted some variability in the abundance of TASOR variants.
TASOR(1-636) and TASOR(1–1000) were barely detectable
suggesting these variants are unstable. There was no correlation
between the relative expression level of the variants and their ability
to support HUSH complex assembly. Given that TASOR(1–1085) is
functional, these data suggest that the Periphilin binding site lies in
residues 1000–1085. Indeed we report elsewhere the crystal
structure of a minimal TASOR–Periphilin complex, showing that
TASOR(1014–1095) contributes directly to binding the Periphilin
C-terminus24. Together these results delineate the biochemical
requirements for HUSH assembly, and suggest that the central
portion of TASOR, spanning residues 350–1085, is a sufficient
assembly scaffold (Fig. 3e).
TASOR DUF3715 is a PARP domain. Having established that
TASOR acts as the core member of HUSH and defined the domains
necessary for assembly, TASOR’s N-terminal DUF3715 stood out as
significant for several reasons: (i) it is required for transgene
repression in a manner independent of assembly; (ii) it is the
domain that differentiates TASOR from S. pombe Chp1 and (iii) it
contains the embryonic lethal mouse mutation (L130P)—under-
lining its key functional role at an organismal level. Bioinformatic
analysis suggested that DUF3715 resembles a poly ADP-ribose
polymerase (PARP) catalytic domain. Functions of the PARP
family, which contains at least 18 members in humans, include
response to genome damage and viral infection40. This is notable
given TASOR’s role as a LINE-1 and viral repressor.
We, therefore, aimed to study the structure and biochemical
properties of DUF3715. Despite extensive trials, we could not
induce the wild-type DUF3715 to crystallize. We used NMR
spectroscopy to gain insight into its structural and dynamic
properties and recorded well-resolved 1H, 15N correlation spectra
on 15N-labeled protein (Fig. 4a). To obtain peak assignments we
required sidechain deuteration and expressed the domain in media
prepared with deuterated water (2H2O). Upon purification in (1H)
aqueous solvents, several peaks in the spectrum were missing,
consistent with a rigid core in which the rate of amide H-D
exchange is exceptionally slow (>5 days). A partial denaturation-
refolding protocol enforced exchange of core amide deuterons
(Supplementary Fig. 4a), enabling assignment of 184 (of 221) non-
proline backbone amide resonances. Secondary structure predic-
tion from chemical shifts41 confirmed an α/β PARP fold with loop
insertions (Supplementary Fig. 4b).
Overall structure and dynamics of the TASOR PARP domain.
NMR assignments allowed us to measure T1 and T2 relaxation
times to investigate domain dynamics (Fig. 4b). The average T1/
T2 ratio is proportional to overall tumbling correlation time τC,
which we determined to be ~15 ns. This value suggests DUF3715
is largely monomeric in solution at 250 µM, though the oligo-
meric status of full-length TASOR remains unknown. Elevated T2
relaxation times for residues 255–270 (the loop connecting
strands β6–β7) were indicative of motions faster than overall
tumbling (τC), in the ns-ps timescale42— commonly described as
disorder (Fig. 4b). A TASOR variant with part of this disordered
loop deleted (Δ261–269) retained transgene repression activity
(Supplementary Fig. 4c).
Hypothesizing that β6–β7 loop disorder precluded crystal-
lization of the wild-type domain, we purified a variant with the
Δ261–269 deletion. Validating our design, crystals were readily
grown of native and SeMet-labeled samples (Supplementary
Fig. 4d), enabling X-ray structure determination of TASOR
DUF3715 to a resolution of 2.0 Å by single-wavelength anomalous
dispersion (SAD) phasing (Supplementary Table 1, Supplementary
Fig. 4e). Comparison with published structures using the Dali
server43 confirmed similarity of the overall fold with PARPs
from various subclasses (Fig. 4c) including canonical poly-
(HsPARP1, PDB:6BHV), mono- (HsPARP10, PDB:3HKV) and
catalytically-inactive (HsZAP/PARP13, PDB:2X5Y) ADP-ribosyl
transferases, and the inactive plant PARP homolog RCD1
(AtRCD1, PDB:5NGO).
The TASOR PARP domain lacks an NAD+ binding site.
PARPs use NAD+ as a cofactor to catalyze addition of one or
more ADP-ribosyl units onto target proteins, although some
PARPs have lost this activity. Since mechanistic studies of ADP-
ribosylation are hampered by a lack of understanding of PARP
substrates, crystal structures have been a useful means to classify
the family into active and inactive members44. The structure
of PARP1 catalytic domain in complex with non-hydrolysable
NAD+ analog benzamide adenosine dinucleotide (BAD) provides
a near-complete picture of interactions made during NAD+
binding45. We tabulated amino acids making ligand contacts in
the PARP1-BAD structure, including the canonical histidine-
tyrosine-glutamate triad required for poly-ADP ribosylation
(Fig. 4d, e). Substitution of the glutamate, as in PARP7 and
PARP10, removes capacity for chain elongation, thus limiting
these enzymes to mono-ADP-ribosylation46. The other residues
involved in NAD+ binding are conserved in active PARPs,
regardless of whether activity is mono- or poly-ADP ribosylation.
By contrast, the human zinc finger antiviral protein (HsZAP, or
PARP13) and Arabidopsis RCD1 lack two or more of the NAD+-
binding residues and are catalytically inactive47,48. In TASOR the
key residues required for catalysis are even more degenerated
than in ZAP or RCD1: all but one of them are replaced by
hydrophobic amino acids (Fig. 4d, f). TASOR shares a further
similarity with ZAP/PARP13, in that the equivalent of its active
site loop or D-loop (TASOR residues 200-210) adopts a closed
conformation relative to PARP1, in which it is open45,47 (Fig. 4e,
f). Together with a short helix spanning residues 294–298, these
features occlude the TASOR ligand-binding pocket and the
sidechain of Tyr295 plugs the nicotinamide binding cleft. Based
on our structure, TASOR therefore lacks the chemical function-
ality and physical space to bind the NAD+ cofactor.
TASOR is a pseudo-PARP that binds weakly to ssRNA. Con-
sistent with our structural data illustrating a degenerate active site,
point mutations removing the only remaining conserved amino
acid (Y217A) or restoring a key NAD+ binding residue (L184H)
did not affect TASOR-dependent transgene repression in cells
(Fig. 5a, b). Differential scanning fluorimetry (DSF) experiments
showed that while the domain was stable in isolation (Tm 51.5 °C),
no change in Tm was observed upon addition of up to 1.5mM
benzamide, a promiscuous NAD+-mimic and PARP inhibitor
(Fig. 5c). By contrast, the catalytic domain of PARP1 showed robust
concentration-dependent stabilization as expected45. We then
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performed a gel-based poly-ADP-ribosylation (PARylation) assay
by mixing recombinant full-length human PARP-1 with the
TASOR PARP domain or negative control BSA. While PARP-1
robustly auto-PARylated in the presence of NAD+ and dsDNA,
shown by a high molecular weight smear in the Coomassie-stained
gel, we did not detect significant evidence of TASOR modification
or auto-modification under the conditions tested (Fig. 5d). We
conclude that TASOR’s active site is non-catalytic in isolation, like
the one in human ZAP/PARP13 (ref. 47).
ZAP — another non-catalytic human PARP — functions by
binding and degrading target viral RNAs49. Because of this and
the association between TASOR and transcription (Fig. 1), we
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were interested to note that recombinant TASOR(106–332)
coeluted with RNA from the E. coli expression host: bound
nucleic acids were sensitive to treatment with high salt and RNase
but not DNase (Supplementary Fig. 4f). The purified domain
bound to various short ssRNA ligands with micromolar affinity in
the presence of 50 mM NaCl, with limited sequence specificity
(Fig. 5e). This interaction was further weakened at higher salt
concentrations, suggesting that binding is non-specific and driven
primarily by electrostatics. Nonetheless, it is plausible that the
PARP domain contributes to RNA binding by full-length
TASOR, or that the TASOR PARP domain binds an as yet
unidentified RNA sequence with high affinity. RNA binding is
consistent with the annotation of TASOR (along with Periphilin)
as part of the HeLa mRNA interactome25,26, and association with
mRNA processing machinery (Fig. 1e). It may be that as in ZAP,
other domains in HUSH confer greater affinity or specificity to
mRNA binding. Taken together, our structural and biochemical
data show that TASOR contains a catalytically-inactive PARP
domain and that, like ZAP and RCD1, TASOR may be
considered a pseudo-PARP50.
PARP loop with concerted motions required for HUSH func-
tions. Topological differences between our structure and the
canonical PARP fold are most pronounced in loops. In particular,
the loop connecting the final two strands (β8 and β9 in TASOR)
spans 14 residues in TASOR (Tyr303–His316), compared to 5
residues in all annotated human PARP family members (Fig. 6a).
In TASOR the extended β8–β9 loop has elevated B-factors in the
crystal structure, and broad NMR peaks caused by fast T2
relaxation (Figs. 4b, 6a). The latter is suggestive of conformational
changes occurring on timescales slower than tumbling time τC
(i.e., ms to µs). Such concerted motions require a higher activa-
tion energy and often correlate with functionally-relevant pro-
cesses like conformational exchange42. This holds true for
TASOR: variants Δ307–312 and Y305A were non-functional in
our transgene repressor assay (Fig. 6b).
We then aimed to further dissect the functional conse-
quences of the Y305A mutation. First, we purified the Y305A
mutant to confirm that it did not cause domain misfol-
ding (Supplementary Fig. 5a). DSF showed that the mutant
(Tm 48.0 °C) was modestly destabilized compared to WT (Tm
51.5 °C) but fully-folded at physiological temperature. In cells,
we confirmed that the Y305A mutant remained localized to the
nucleus (Fig. 6c). Moreover, the ΔPARP deletion mutant
remained chromatin-associated (Supplementary Fig. 5b) and
both TASOR Y305A and ΔPARP also associated with the same
set of cellular proteins as the WT protein in BioID experiments
(Supplementary Fig. 5c). Together, these data are consistent
with a model in which the pseudo-PARP domain is not
required for chromatin localization nor HUSH assembly,
although it remains possible that it contributes to TASOR
targeting under certain conditions. Finally, we asked whether
the Y305A mutation affected LINE-1 repression and TASOR-
regulated H3K9me3 deposition. Expression of LINE-1 orf1p in
TASOR KO cells was partially re-repressed by expression of
WT TASOR but not the ΔPARP or Y305A variants (Fig. 6d).
CUT&RUN profiling showed that the Y305A point mutation
caused a near-complete loss of H3K9me3 deposition at the
393 sites we defined to represent TASOR-regulated H3K9me3,
an effect functionally equivalent to TASOR KO (Fig. 6e, f). We
conclude that the extended, dynamic β8–β9 loop — conserved
in TASOR but unique among the human PARP family — is
necessary not only for reporter transgene repression but also for
genome-wide H3K9me3 deposition and LINE-1 repression
by HUSH.
Discussion
This study provides a molecular characterization of TASOR and
how it contributes to HUSH function. We have shown that
TASOR is as an assembly platform for MPP8 and Periphilin, and
we have identified the minimal molecular determinants of HUSH
complex assembly. TASOR(525–633) interacts with MPP8
(500–560), and TASOR(1000–1085) interacts with Periphilin
(285–374)24 (Fig. 3).
We report striking homology in the domain organization of the
HUSH complex and the yeast RNA-induced transcriptional
silencing (RITS) complex (Fig. 1). The core subunits of each
complex, TASOR and Chp1, both contain a SPOC domain and
C-terminal DomII/PIN domains. Both complexes also contain
chromodomains — in MPP8 and Chp1, respectively — that
recognize H3K9me3-marked chromatin. Chp1 binding partner
Tas3 also resembles HUSH subunit Periphilin: both are largely
unstructured with low-complexity sequences and C-terminal
helical repeats. Homology between RITS and HUSH is particu-
larly interesting in light of several functional similarities between
the two complexes. Both HUSH and RITS affect H3K9me3
deposition over targets, and rely on self-association (of Periphilin
or Tas3) to spread this epigenetic mark24,37. In RITS H3K9me3
deposition is induced by a positive feedback loop based on
recognition of nascent repetitive transcripts. Observations that
MPP8 genome binding is enhanced by LINE-1 transcription15
and that TASOR and Periphilin are mRNA binding proteins24–26
are, therefore, pertinent. The functional relationship between
HUSH and RITS is further supported by our epigenomic profiling
of TASOR-regulated H3K9me3, which strengthens the notion
that HUSH targets for H3K9 methylation in human cells are
primarily intronic L1P repeats, or repetitive exons in transcribed
genes. It remains unclear how recognition of an RNA inter-
mediate by HUSH and H3K9 methylation of HUSH loci by
SETDB1/ATF7IP might be linked. The H3K9me3 mark is not
solely spread via a simple read-write mechanism involving MPP8
and SETDB1, as the MPP8 chromodomain is not required to
maintain pre-established repression but TASOR and Periphilin
are11. Another domain, such as the TASOR pseudo-PARP
domain, could be required to activate SETDB1. Alternatively, a
specific structure or compact physical state of the chromatin,
generated by HUSH effector MORC2 (refs. 13–15), may be
necessary to license target loci for SETDB1 methylation.
HUSH target elements have in common the potential to cause
genome damage if incorrectly processed. HUSH may therefore
play a role in controlling the rate of transcription of these ele-
ments. RNA Polymerase II (Pol II) is known to transcribe
H3K9me3-marked and repetitive regions more slowly51,52. We
have reported elsewhere that Periphilin aggregates through a low-
complexity sequence reminiscent of disordered RNA-binding
proteins24. The formation of Periphilin-RNA aggregates could
potentially physically impede transcriptional elongation by Pol II.
Our protein–protein interaction screen identified several nuclear
RNA processing factors as TASOR binders (Fig. 1). One notable
example is RPRD2, another LINE-1 repressor15, which regulates
transcription by directly binding Pol II53. HUSH-dependent
H3K9me3 could similarly reduce transcription rates to prevent R-
loop formation at genomic regions prone to instability31, or to
ensure correct mRNA processing (e.g., splicing). Indeed, intronic
LINE-1s are thought to function as hubs of transcriptional
repression that protect long mammalian introns from improper
splicing54. Local chromatin compaction by HUSH effector
MORC2 may provide an additional protective barrier of repres-
sion14. Loss of these repressive barriers should cause transcription
rates to increase, potentially leading to improper processing and
genome instability. This may explain the developmental arrest
observed in mouse TASOR mutants at the onset of gastrulation12.
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A potential role for HUSH in genome protection is consonant
with our discovery of a pseudo-PARP domain in TASOR. PARPs
are central regulators of genome stability, which can be com-
promised by inappropriate recombination or retrotransposition.
We found that the TASOR pseudo-PARP domain is critical for
transgene repression (Fig. 2), despite being dispensable for HUSH
assembly. Unlike canonical PARPs, TASOR appears from
our crystal structure to be incompetent for catalysis (Figs. 4, 5).
There are intriguing functional parallels between TASOR and
ZAP (PARP13), which is also catalytically inactive. ZAP binds
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repetitive RNA sequences55, influences the destruction of target
RNAs56 and inhibits LINE-1 retrotransposition57. We have
identified that TASOR activity relies on an extended loop unique
among the PARP family, and a single point mutation (Y305A) in
this loop is sufficient to abolish transgene repression, endogenous
LINE-1 restriction and genome-wide H3K9me3 deposition
(Fig. 6). Structural studies with larger fragments of HUSH in
complex with chromatin or RNA will be necessary to illuminate
the basis for this loss of function. In light of our NMR data we
speculate that the Y305A mutation inhibits a conformational
change within the chromatin-engaged HUSH complex, leading to
a loss of H3K9me3 deposition and HUSH-mediated repression.
Whether the Y305A mutation inhibits SETDB1 activity directly
or indirectly (e.g., via changes to chromatin structure) requires
further investigation.
Our findings have implications for how HUSH regulation
is established and maintained over newly integrated genetic
elements such as retroviruses. This is clinically important in the
context of HIV latency and gene therapy58. We reported pre-
viously that HUSH represses transgenes that integrate into
H3K9me3-marked chromatin. However, the requirement for
the pseudo-PARP domain and Periphilin self-association24 in
HUSH function (but not assembly) underscores that H3K9me3
reading and writing is insufficient to explain HUSH activities.
Whether HUSH has H3K9me3-independent modes of recruit-
ment to target sequences also remains to be resolved. Silencing
of unintegrated murine retroviral DNA by HUSH requires
NP220 (ref. 17), a DNA- and RNA-binding protein thought to
be at least partly sequence-specific for cytidine clusters59. We
find that NP220 and another matrin-type ZNF (ZNF318)
interact with TASOR in the absence of virus, raising the pos-
sibility that multiple specific adapters could recruit HUSH in
different contexts. We note that although nucleotide sequences
are one source of specificity in epigenetic repression, in the case
of HUSH, specificity could also arise from RNA structure or the
repetitiveness of a nucleotide sequence.
Methods
Cell culture. HeLa and HEK293T cells (ECACC) were grown in IMDM or DMEM
plus 10% fetal calf serum (FCS) and penicillin/streptomycin (100 U/mL). Cell lines
were routinely tested for mycoplasma contamination using the MycoAlert detec-
tion kit (Lonza).
Antibodies. The following primary antibodies were used: rabbit α-TASOR (Atlas
HPA006735, RRID:AB_1852384 for ChIP, CUT&Tag and western blot); rabbit α-
TASOR (abcam ab224393, for microscopy); rat α-mCherry (Thermo Fisher Sci-
entific, M11217, RRID:AB_2536611); rabbit α-MPP8 (Proteintech, 16796-1-AP,
RRID:AB_2266644); rabbit- α-V5 (Abcam, ab27671, RRID:AB_471093); mouse α-
Myc (Abcam, ab32, RRID:AB_303599); mouse α-FLAG (Millipore Sigma, F1804,
RRID:AB_262044; rabbit α-PPHLN1 (Abcam, ab69569, RRID:AB_1269877); rab-
bit α-H3K9me3 (abcam ab8898, RRID:AB_306848, for CUT&RUN and CUT&-
Tag); rabbit α-H3K27me3 (CST C36B11, RRID:AB_2616029, for CUT&RUN
positive control); guinea pig α-rabbit IgG (CSB-PA00150E1Gp, for CUT&Run and
CUT&Tag); rabbit IgG (CST 2729, RRID:AB_1031062 for ChIP negative control);
rabbit α-ORF1p (CST D3W9O, RRID:AB_2800129); mouse α-β-actin (abcam
ab8226, RRID:AB_306371). Dilutions were made according to manufacturer
recommendations unless otherwise stated.
Lentiviral expression. Exogenous expression of TASOR variants and other HUSH
components was achieved using the lentiviral expression vectors pHRSIN-pSFFV-
GFP-WPRE-pPGK-Hygro, pHRSIN-pSFFV-GFP-WPRE-pPGK-Blasto or
pHRSIN-pSFFV-GFP-pPGK-Puro with mCherry-TASOR (full-length or mutant),
HA-BirA-TASOR (full-length or mutant), V5-PPHLN1 or myc-SETDB1 cassettes
inserted in place of GFP. Lentivirus was generated through the triple transfection of
HEK 293T cells with the lentiviral transfer vector plus the two packaging plasmids
pCMVΔR8.91 and pMD.G using TransIT-293 transfection reagent (Mirus) as
recommended by the manufacturer. Viral supernatant was typically harvested 48 h
post-transfection, cell debris removed using a 0.45 µm filter, and target cells
transduced by spin infection at 800 g for 1 h. Transduced cells were selected with
hygromycin (100 µg/mL), blasticidin (5 µg/mL) or puromycin (2 µg/mL).
Co-immunoprecipitation and western blotting. For co-immunoprecipitation,
cells were lysed in 1% NP-40 in TBS plus 10 mM iodoacetamide, 0.5 mM phe-
nylmethylsulfonyl fluoride (PMSF) and benzonase (Sigma-Aldrich) for 30 min.
Protein A and IgG-sepharose resin was added to the lysates along with primary
antibody. The suspension was incubated for 2 h at 4 °C and the resin was washed
three times in lysis buffer. For western blotting, cells were lysed with lysis buffer
containing 1% SDS instead of 1% NP-40. For SDS-PAGE analysis, resins or lysates
were heated to 70˚C in SDS sample buffer for 10 min and run on a polyacrylamide
gel. Gels were blotted onto PVDF membranes (Millipore). Blots were blocked in
5% milk in PBS, 0.2% Tween-20 and incubated with primary antibody diluted in
blocking solution. As the Periphilin antibody was unable to detect its epitope under
NP-40 lysis conditions, we used a mouse antibody against the V5 tag (Abcam,
ab27671) as the primary antibody for Periphilin. For TASOR, the primary antibody
was rabbit α-TASOR (Atlas, HPA006735). Blots were imaged with West Pico or
West Dura (Thermo Fisher Scientific).
Flow cytometry. Cells were fixed in 1% PFA and analyzed on a FACSCalibur or a
FACSFortessa instrument (BD). Data were analyzed using FlowJo (v10) software.
For cell sorting, cells were resuspended in PBS+ 2% FCS and an Influx cell sorter
(BD) was used.
CUT&RUN. We followed the protocol detailed by the Henikoff lab27. Briefly,
1–2.5 × 105 cells (per antibody/cell line combination) were washed twice (20 mM
HEPES pH 7.5, 150 mM NaCl, 0.5 mM spermidine, 1× Roche complete protease
inhibitors) and attached to ConA-coated magnetic beads (Bangs Laboratories) that
had been pre-activated in binding buffer (20 mM HEPES pH 7.9, 10 mM KCl, 1
mM CaCl2, 1 mM MnCl2). Cells bound to the beads were resuspended in 50 µL
buffer (20 mM HEPES pH 7.5, 0.15M NaCl, 0.5 mM Spermidine, 1× Roche
complete protease inhibitors, 0.02% w/v digitonin, 2 mM EDTA) containing pri-
mary antibody (1:100 dilution). Incubation proceeded at 4 °C for at least 2 h
(usually overnight) with gentle shaking. Tubes were then placed on a magnet stand
to allow removal of unbound antibody, and washed three times with 1 mL digi-
tonin buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.5 mM Spermidine, 1× Roche
complete protease inhibitors, 0.02% digitonin). After the final wash, pA-MNase
(35 ng per tube, a generous gift from Steve Henikoff) was added in a volume of 50
µL of the digitonin buffer and incubated with the bead-bound cells at 4 °C for 1 h.
Beads were washed twice, resuspended in 100 µL of digitonin buffer, and chilled to
0–2 °C. Genome cleavage was stimulated by addition of 2 mM CaCl2 (final), briefly
vortexed and incubated at 0 °C for 30 min. The reaction was quenched by addition
of 100 µL 2× stop buffer (0.35 M NaCl, 20 mM EDTA, 4 mM EGTA, 0.02% digi-
tonin, 50 ng/µL glycogen, 50 ng/µL RNase A, 10 fg/µL yeast spike-in DNA (a
generous gift from Steve Henikoff)) and vortexing. After 10 min incubation at 37 °
C to release genomic fragments, cells and beads were pelleted by centrifugation
(16,000 × g, 5 min, 4 °C) and fragments from the supernatant purified with a
Nucleospin PCR clean-up kit (Macherey-Nagel). Experimental success was eval-
uated by capillary electrophoresis (Agilent) with this material and the presence of
nucleosome ladders for histone modifications (H3K27me3 or H3K9me3) but not
for IgG controls. Illumina sequencing libraries were prepared using the Hyperprep
kit (KAPA) with unique dual-indexed adapters (KAPA), pooled and sequenced on
a HiSeq4000 or NovaSeq6000 instrument. Paired-end reads (2 × 150) were aligned
to the human and yeast genomes (hg38 and R64-1-1, respectively) using Bowtie2
(v2.3.4.3; --local –very-sensitive-local –no-mixed –no-discordant –phred33 -I 10
-X 700) and converted to bam files with samtools (v1.9)60,61. Conversion to bed-
graph format and normalization was done with bedtools genomecov (v2.27.1; -bg
-scale), where the scale factor was the inverse of the number of reads mapping to
the yeast spike-in genome62. Peaks were called in SEACR63 (v1.1; stringent, norm
options) for experimental samples against IgG controls. The RUVseq package
(v1.20) was used to remove unwanted variation prior to differential binding ana-
lysis with edgeR (v3.28.1)64,65. TASOR-regulated H3K9me3 peaks were defined as
those under a cutoff in the MA plot (log2 fold-change <−1) of KO vs control cells.
CUT&RUN experiments to assess H3K9me3 regulation were done with four
replicates (control and TASOR KO cells, used to define TASOR-regulated peaks) or
two replicates (WT and Y305A complemented cells, used to assess H3K9me3
complementation over TASOR-regulated peaks). Normalized bigwig files were
generated (UCSC), displayed in IGV (v2.4.9)66 and heatmaps plotted with deep-
Tools computeMatrix and plotHeatmap commands (v3.3.0). Replicate correlations
were assessed with deepTools multiBigWigSummary and plotCorrelation com-
mands67 (Supplementary Fig. 6).
ChIP-seq. Cells (10 million per IP) were washed once in PBS, resuspended in
growth medium, and then cross-linked in 1% formaldehyde for 10 min. The
reaction was quenched by adding glycine to a final concentration of 0.125 M for
5 min before the cells were lysed in cell lysis solution (10 mM HEPES pH 7.5, 85
mM KCl, 0.5% IGEPAL). Nuclei were pelleted by centrifugation, and then resus-
pended in nuclear lysis solution (50 mM Tris pH 8.1, 10 mM EDTA, 1% SDS) for
10 min. The chromatin was sheared using a Bioruptor (Diagenode, high power, 20
cycles of 30 s with 30 s recovery) to obtain a mean fragment size of ~300 bp.
Insoluble material was removed by centrifugation. The chromatin solution was pre-
cleared with protein A sepharose (Sigma-Aldrich), 10% retained (input) and then
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chromatin immunoprecipitated overnight using 5 µg primary antibody (rabbit IgG
or rabbit α-TASOR) and protein A sepharose. The next day the beads were washed
a total of five times, and then bound protein-DNA complexes eluted in 0.15M
NaHCO3 and 1% SDS. Cross-links were reversed by overnight incubation at 67 °C
with 0.3 M NaCl and 1 µg RNase A. Proteinase K (60 µg) was then added and the
samples incubated for 2 h at 45 °C. DNA was purified using a spin column (Qiagen
PCR purification kit). Illumina sequencing libraries were produced from this
material using the TruSeq kit (Illumina), and sequenced on a HiSeq 2500 instru-
ment. Single-end reads (1 × 50) were aligned to the human genome (hg38) using
Bowtie2 with default parameters and converted to bam files with samtools60,61.
Coverage plots for input and ChIP (IgG and TASOR) samples were generated
using bamCoverage (deepTools), with reads extended (250 bp) and normalized
using RPGC (reads per genomic context; chrX ignored) with an effective genome
size of 2913022398 (hg38)67. ChIP experiments were done once. Normalized
bigwig files were displayed in IGV66 and heatmaps generated with deepTools
computeMatrix and plotHeatmap commands67.
CUT&Tag. We followed the protocol detailed by the Henikoff lab28 with alterations
made after consultation with protocol authors, or due to the method being under
regular review and optimization. 100,000 cells were washed twice (20 mM HEPES
pH 7.5, 0.15 M NaCl, 0.5 mM spermidine, 1× Roche complete protease inhibitors)
and attached to activated ConA-coated magnetic beads (Bangs Laboratories) at RT
for 15 min. Cells bound to the beads were resuspended in 100 µL buffer (20 mM
HEPES pH 7.5, 0.15M NaCl, 0.5 mM Spermidine, 1× Roche complete protease
inhibitors, 0.05% digitonin (Millipore), 2 mM EDTA) containing primary antibody
(1:50 dilution). Incubation proceeded at RT for 2 h with gentle shaking. Tubes were
placed on a magnet stand to allow removal of unbound antibody. The secondary
antibody (guinea pig anti-rabbit IgG, 0.25 g/L) was added at 1:100 dilution and cells
incubated at RT for 1 h with gentle shaking. Cells were washed three times on the
magnet in 1 mL buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.5 mM Spermidine,
1× Roche complete protease inhibitors, 0.05% digitonin). Meanwhile pA-Tn5
adapter complex (40 nM, a generous gift from Steve Henikoff) was prepared in a
higher salt, lower digitonin buffer (20 mM HEPES, pH 7.5, 0.35M NaCl, 0.5 mM
spermidine, 1× Roche complete protease inhibitors, 0.01% digitonin). This buffer
had a slightly increased NaCl concentration over that recommended in the pro-
tocol, to reduce non-specific binding to open chromatin (the so-called ATAC-seq
artifact). After the final wash, 100 µL of pA-Tn5 solution was added to the bead-
bound cells with gentle vortexing and the cells incubated at RT for 1 h with gentle
shaking. Cells were then washed three further times in 1 mL buffer, before resus-
pension in 50 µL tagmentation buffer (20 mM HEPES pH 7.5, 0.35M NaCl, 10 mM
MgCl2, 0.5 mM spermidine, 1× Roche complete protease inhibitors, 0.01% digi-
tonin). Tagmentation was allowed to proceed at 37 °C for 1 h before quenching
with 20 mM EDTA, 0.5% SDS (both final concentrations) and 10 µg Proteinase K
(Thermo Fisher Scientific). The mixture was incubated at 37 °C overnight. The next
day, tubes were incubated at 70 °C for 20 min to further inactivate the protease.
DNA was extracted from the mixture with 2.2× SPRI beads (KAPA). After twice
washing the beads with 80% EtOH, DNA was eluted in 25 µL water. For PCR,
21 µL DNA was mixed with 2 µL of 10 µM universal i5 primer (AATGATACGG
CGACCACCGAGATCTACACTCGTCGGCAGCGTCAGATGTG) and 2 µL of
10 µM uniquely-barcoded i7 primer (CAAGCAGAAGACGGCATACGAGAT[i7]
GTCTCGTGGGCTCGGAGATGT), then 25 µL NEBNext HiFi 2× PCR Master
mix was added and pipette mixed. The following thermocycler program was used:
72 °C for 5 min; 98 °C for 30 s; 13 cycles of 98 °C for 10 s and 63 °C for 30 s; final
extension at 72 °C for 1 min and hold at 8 °C. Post-PCR clean-up was performed
with 1.1× SPRI beads (KAPA). Libraries were pooled in approximately equimolar
ratios based on capillary electrophoresis (Agilent) and/or fluorometry (Thermo
Fisher Scientific) quantification results, before final left-sided size selection (1.1×
SPRI) to remove residual PCR primers. Paired-end reads (2×150 bp) were gener-
ated on a HiSeq 4000 instrument (Illumina). Reads were aligned to the human
genome (hg38) using Bowtie2 (--local –very-sensitive-local –no-mixed –no-dis-
cordant -I 10 -X 700) and converted to bam files with samtools60,61. PCR duplicates
were removed using Picard (http://broadinstitute.github.io/picard/) before con-
version to bedgraph file format (bedtools)62. Coverage plots for display and
comparison of tracks were generated using bamCoverage (deepTools)67 after
downsampling bam files to the control/KO sample based on the final number of
mapped reads. We note that this is a conservative approach, because library
complexity is related to the number of true binding sites in such a targeted
experiment. CUT&Tag experiments to assess TASOR binding were done in bio-
logical duplicate. Resulting bigwig files were displayed in IGV66 and heatmaps
made with deepTools computeMatrix and plotHeatmap packages. Replicate cor-
relations were assessed with deepTools multiBigWigSummary and plotCorrelation
commands67 (Supplementary Fig. 6).
RNA-seq analysis. Paired-end (2 × 150) reads from HeLa RNA-seq experiments
that we reported elsewhere14 were re-mapped to hg38 using HiSat2 (v2.1.0; --no-
mixed –no-discordant) then converted to bam files in samtools61,68. Fragments
overlapping representative transcripts from annotated human genes (gencode v29)
were counted in the featureCounts tool (--primary –fraction -t exon -p) from the
subread package (v1.6.4)69 and the mean taken of the three replicates.
BioID. The following protocol was adapted from a published protocol70. TASOR
knockout cells expressing HA-BirA-tagged TASOR variants were grown in square
500 cm2 dishes (Corning) in DMEM, which was supplemented with 50 μM biotin
for 18 h prior to downstream processing. After washing with PBS, cells were scraped
in PBS before pelleting (400 × g, 5 min, RT). Nuclei were isolated by resuspending
cells in 10mL nuclear isolation buffer (1 mM HEPES, 85mM KCl, 0.5% IGEPAL)
before being pelleted again (800 × g, 5 min, 4 °C). Nuclear pellets were lysed by
sonication on ice in 10mL lysis buffer (50mM Tris pH 7.4, 0.5M NaCl, 0.4% SDS,
5 mM EDTA, 1 mM DTT, 1× Roche complete protease inhibitor). After sonication,
Triton X-100 concentration was adjusted to 2% and NaCl concentration to 150mM.
Lysates were then centrifuged (16,000 × g, 10 min, 4 °C). Protein concentration was
measured by BCA assay (Pierce) and equal amounts taken for further steps. Samples
were incubated with 50 μL pre-equilibrated magnetic Dynabeads MyOne Strepta-
vidin C1 at 4 °C overnight on a rotating wheel. The next day, a series of washing
steps were carried out at RT, each twice for 5 min unless otherwise stated. Wash
buffer 1 contained 2% SDS, 50mM TEAB pH 8.5, 10mM TCEP, 20mM iodoa-
cetamide (30min incubation). Wash buffer 2 contained 50mM HEPES pH 7.4, 1
mM EDTA, 500mM NaCl, 1% Triton X-100, 0.1% Na-deoxycholate. Wash buffer 3
contained 10mM Tris pH 8.0, 0.25M LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% Na-
deoxycholate. Wash buffer 4 contained 50 mM Tris pH 7.4, 50mM NaCl, 0.1% NP-
40. Wash buffer 5 contained 50 mM TEAB pH 8.5, 6M urea. Wash buffer 6
contained 50mM TEAB pH 8.5. Finally, beads were resuspended in 50 µL 50mM
TEAB pH 8.5 containing 0.1% Na-deoxycholate and 200 ng of trypsin (Promega),
before incubation overnight at 37 °C with periodic shaking (Eppendorf Thermo-
mixer). After removing the beads digests were subjected to clean-up using SDP-RPS
extraction material (Affinisep) backed into 200 µL pipette tips. Columns were
conditioned with 100 µL ACN followed by 100 µL 0.5% TFA. Samples were acidified
with a final concentration of 0.5% TFA and an equal volume of ethyl acetate loaded
onto the columns. Columns were then washed with 100 µL 0.2% TFA and 100 µL
ethyl acetate and eluted in 80% ACN+ 5% ammonium hydroxide. Samples were
dried under vacuum and stored at −20 °C prior to analysis.
Mass spectrometry. Samples were resuspended in 10 µL 5% DMSO, 0.5% TFA
and the whole sample injected. Data were acquired on an Orbitrap Fusion mass
spectrometer (Thermo Scientific) coupled to an Ultimate 3000 RSLC nano UHPLC
system (Thermo Scientific). Samples were loaded at 10 μL/min for 5 min on to an
Acclaim PepMap C18 cartridge trap column (300 µm × 5mm, 5 µm particle size) in
0.1% TFA. After loading, a linear gradient of 3–32% solvent B over 60min was used
for sample separation with a column of the same stationary phase (75 µm × 75 cm,
2 µm particle size) before washing at 90% B and re-equilibration. Solvents were A:
0.1% FA and B: ACN/0.1% FA. MS settings were as follows. MS1: quadrupole
isolation, 120,000 resolution, 5e5 AGC target, 50 ms maximum injection time, ions
accumulated for all parallelisable time. MS2: quadrupole isolation at an isolation
width of m/z 0.7, HCD fragmentation (NCE 34) with the ion trap scanning out in
rapid mode from, 8e3 AGC target, 0.25 s maximum injection time, ions accumu-
lated for all parallelisable time. Target cycle time was 2 s. Spectra were searched by
Mascot within Proteome Discoverer 2.2 in two rounds of searching. The first search
was against the Uniprot human reference proteome and compendium of common
contaminants (GPM). The second search took all unmatched spectra from the first
search and searched against the human trEMBL database. The following search
parameters were used. MS1 Tol: 10 ppm, MS2 Tol: 0.6 Da, fixed mods: carba-
mindomethyl (C); var mods: oxidation (M), enzyme: trypsin (/P). Peptide spectrum
match (PSM) FDR was calculated using Mascot percolator and was controlled at
0.01% for ‘high’ confidence PSMs and 0.05% for ‘medium’ confidence PSMs. Pro-
teins were quantified using the Minora feature detector within Proteome Discoverer.
Western blotting. Cells were lysed in 1% SDS plus 1:100 (v/v) benzonase (Sigma)
for 15 min at room temperature, and then heated to 65 °C in SDS sample loading
buffer for 5 min. Following separation by SDS-PAGE, proteins were transferred to
a PVDF membrane (Millipore), which was then blocked in 5% milk in PBS+ 0.2%
Tween-20. Membranes were probed overnight with the indicated primary anti-
bodies, washed four times in PBS+ 0.2% Tween-20, then incubated with HRP-
conjugated secondary antibodies for 1 h at RT. Reactive bands were visualized
using SuperSignal West Pico (Thermo Fisher Scientific). Alternatively, after SDS-
PAGE, proteins were transferred to a nitrocellulose membrane (Thermo Fisher
Scientific iBlot2), which was blocked in 5% milk in PBS (no detergent) for 1 h.
Membranes were probed overnight with the indicated primary antibodies in 5%
milk in PBS+ 0.1% Tween-20, washed thoroughly in PBS+ 0.1% Tween-20, then
incubated with DyLight-680 or 800-conjugated secondary antibodies (Thermo
Fisher Scientific) at 1:10,000 dilution for 30 min at RT. After thorough washing
with PBS-Tween, PBS and then water, blots were imaged on the Odyssey near-
infrared system (LI-COR). Uncropped blots are shown in Supplementary Fig. 7.
Subcellular fractionation. Cells were washed twice in PBS and once in buffer A
(10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol (DTT)
and protease inhibitor cocktail). Cells were then pelleted and resuspended in buffer
A with 0.1% (v/v) NP40 and incubated on ice for 10 min. The supernatant con-
taining the cytoplasmic fraction was collected following centrifugation (1300 × g,
4 min, 4 °C) and further clarified by high-speed centrifugation (20,000 × g, 15 min,
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4 °C). The remaining pellet was washed in buffer A without NP40 and resuspended
in an equal volume (relative to the cytoplasmic extract) of buffer B (20 mM HEPES
pH 7.9, 1.5 mMMgCl2, 0.3 M NaCl, 0.5 mM DTT, 25% (v/v) glycerol, 0.25% Triton
X-100, 0.2 mM EDTA and protease inhibitor cocktail). The supernatant containing
the soluble nuclear fraction was collected following centrifugation (1,700 g, 4 min,
4 °C), and the insoluble pellet, composed primarily of chromatin and associated
proteins, was resuspended in an equal volume of Laemmli buffer (relative to the
cytoplasmic and soluble nuclear extracts). Equal volumes of cytoplasmic, soluble
and insoluble nuclear fractions were separated by SDS-PAGE, transferred to a
PVDF membrane (Millipore) and probed with relevant antibodies.
Confocal immunofluorescence microscopy. Cells were fixed for 15 min with 4%
formaldehyde in PBS, permeabilized for 5 min with 0.1% TritonX-100 in PBS and
then blocked with 2% BSA in PBS for 1 hour. Cells were stained with primary
antibodies at 1:200 dilution in blocking buffer and, after further washing, with
secondary antibody (anti-rabbit AlexaFluor 647, 1:500 dilution) in blocking buffer
for 1 h. Samples were washed thoroughly and cover slips mounted on microscopy
glasses with ProLong Gold anti-fade reagent with DAPI (Invitrogen). Imaging was
performed using Nikon Ti microscope equipped with CSU-X1 spinning disc
confocal head (Yokogawa) and with Zeiss 780 system.
Protein expression and purification. A synthetic E. coli codon-optimized DNA
construct (IDT) encoding TASOR residues 106–332 (UniProt Q9UK61-1) was
cloned into the expression vector pET-15b for production of the N-terminally
thrombin-cleavable His6-tagged protein product
(MGSSHHHHHHSSGLVPRGSHM[…]). Mutation of this construct to generate
variants Y305A or the construct used for crystallography (110–332 Δ261–269) were
done with standard methods. Transformed E. coli BL21(DE3) cells (NEB) were
grown at 37 °C in 2xTY media containing 100 mg/L ampicillin. Expression was
induced at an OD600 of 0.8 with 0.2 mM IPTG for 18 h at 18 °C. The culture was
pelleted and resuspended in a buffer containing 50 mM Tris pH 8.0, 0.15M NaCl,
10 mM imidazole, 1 mM DTT and 1× Roche complete EDTA-free protease inhi-
bitors, then flash frozen in liquid nitrogen and stored at −80 °C. All subsequent
steps were done at 4 °C unless otherwise stated. Further lysis was achieved by
extensive sonication (3 × 3 min). A solution of benzonase (1:10,000 v/v final con-
centration, Sigma) was added and after 30 min incubation with stirring, the NaCl
concentration was adjusted to 0.5 M, otherwise the protein co-purified with host
RNA. The lysate was clarified by centrifugation (15,000 × g, 45 min) and the
protein-containing supernatant bound to preequilibrated Ni-NTA beads (Generon)
for 1 h with rocking. The beads were washed with at least 20 CV Ni wash buffer
(50 mM Tris, pH 8.0, 0.5 M NaCl, 10 mM imidazole, 1 mM DTT) before a stepwise
elution in batch mode with 3 × 5 CV of Ni wash buffer supplemented with 0.2 M,
0.3 M and 0.5 M imidazole. Further purification was achieved with size-exclusion
chromatography on a Superdex 200 increase (10/300) column (GE) in buffer (50
mM HEPES, pH 7.5, 0.2 M NaCl, 0.5 mM TCEP). For crystallography trials and
NMR experiments, the His6-tag was cleaved with restriction-grade thrombin
(Millipore) overnight on ice in Tris buffer supplemented with 2.5 mM CaCl2. The
next day the protease was removed by incubation with 100 µL benzamidine
sepharose beads (GE) for 5 min at RT. For crystallography trials an additional ion
exchange chromatography step with a monoS column was included in the protocol.
Tag cleavage was done after the Ni-affinity step, before size exclusion and ion
exchange chromatography steps. For SeMet-labeled protein, expression was repe-
ated in minimal media containing L-(+)-selenomethionine (Anatrace), using an
established strategy71. Single 15N labeling, double 13C/15N labeling or triple 2H/
13C/15N labeling for NMR experiments required expression in minimal media
made with 15NH4Cl, 13C glucose and/or D2O (Sigma) as appropriate. Cultures in
D2O grew more slowly and were therefore kept at 25 °C throughout. Purification of
these labeled samples otherwise followed the protocol used for unlabeled samples.
For co-expression of the TASOR-MPP8 complex in E. coli, we co-transformed
BL21(DE3) cells with the pET15b vector harboring His-tagged TASOR(354–633)
and the pRSF vector harboring MPP8(527-860) (UniProt Q9UK61-1, Q99549-1).
The proteins were expressed by growing the cells in autoinduction media for 60 h
at 18 °C, and the complex purified by Ni-affinity purification. Eluates were
concentrated and analyzed by SEC-MALS at 293 K using a Superdex 200 (10/300)
column in a buffer containing 20 mM HEPES pH 7.5, 0.5 M NaCl, 0.5 mM TCEP.
Light scattering analysis was performed in the ASTRA software package (Wyatt),
using band broadening parameters obtained from a BSA standard run on the same
day under identical conditions. MALS data were used to fit the average molar mass
across the complex peak (quoted to the nearest kDa).
Expression of full-length His-tagged HsPARP-1 and the in vitro gel-based
PARylation assay followed a detailed protocol published elsewhere72.
NMR. NMR data were collected at 298 K using a Bruker Avance II+ 700MHz
spectrometer with triple resonance cryoprobe unless otherwise stated. All samples
were prepared with 5% D2O as a lock solvent, in PBS (pH 7.0) supplemented with
1 mM TCEP and 0.05% w/v NaN3, and degassed prior to data acquisition. 1H-15N
BEST-TROSY (band selective excitation short transient transverse relaxation
optimized spectroscopy) spectra were collected for the 15N labeled WT TASOR
sample and the 2H/13C/15N WT TASOR sample using an optimized pulse
sequence73. An initial, incomplete assignment of WT TASOR was carried out using
standard TROSY based triple resonance spectra with deuterium decoupling:
trHNCO and trHNCACO with 2048*64*128 complex points in the 1H, 15N and
13C dimensions respectively, trHNCA and trHNCOCA with 2018*64*160 complex
points in the 1H, 15N and 13C dimensions respectively and trHNCACB and
trHNCOCACB with 2048*64*110 complex points in the 1H, 15N and 13C
dimensions, respectively. This assignment revealed a subset of residues without
peak data. A comparison of 2D projections with a limited number of equivalent
triple resonance experiments collected on a 15N/13C only labeled sample revealed
additional peak data. This indicated that the deuterated sample had incomplete
back exchange of the solvent exchangeable backbone NH protons within the core
of the protein. Partial denaturation of the 13C/15N/2H sample with 3.5 M urea in
PBS, followed by incremental stepwise dilution of urea back to 0M, allowed back-
exchange and additional data sets were collected to complete the assignment. These
additional experiments included trHNCACB, trHNCA, trHNCACO, trHNCO, and
trHNCOCA spectra recorded as above. All triple resonance data sets were collected
with 20–40% Non-Uniform Sampling (NUS) and processed using compressed
sensing74. All 2D data sets were processed using Topspin version 3.1 or higher
(Bruker) and all spectra analyzed using Sparky 3.115. The assignment was com-
pleted for 184/221 non-proline backbone amide resonances using MARS75. The
dynamic properties of TASOR were investigated using standard Bruker T1 and T2
relaxation pulse programs. T1 and T2 data sets were collected on an Avance III HD
800MHz spectrometer fitted with a triple resonance cryoprobe and T1 delays of 50,
100, 200, 500, 800, 1500, 2200, and 3000 ms and T2 delays of 16, 32, 48, 64, 96, 128,
160, and 192 ms. Signal intensity measurements and slope fitting was completed
using Sparky. A second, higher-resolution T2 data set was collected at 950MHz
(Bruker Avance III HD) using the same relaxation delays.
X-ray crystallography. TASOR PARP domain (residues 110–332 with internal
deletion of residues 261–269 and His6 tag cleaved), native or SeMet-labeled, was
concentrated to 8 g/L (320 µM) in buffer containing 20mM HEPES pH 7.5, 0.15M
NaCl, 0.5mM TCEP. Crystals were grown at 18 °C by the sitting drop vapor diffusion
method, by mixing the protein at a 1:1 ratio with reservoir solution containing 0.1M
MES pH 6.5, 0.1M NaPi, 0.1M KPi, 2M NaCl. Crystals appeared in overnight and
were frozen within 2 d in liquid N2 using paraffin oil as a cryoprotectant. X-ray
diffraction data were collected at 100 K at Diamond Light Source beamlines i02 and
i03. Native and selenium-substituted data sets were collected with X-ray wavelengths
of 0.97949 Å and 0.97980 Å, respectively. Data sets were processed using autoproc or
xia2 packages76,77. Automatic experimental phasing was done in AutoSol (Phenix)78
using the single anomalous dispersion (SAD) method with selenium as the heavy
atom. The resulting model was built and refined in Coot79 and Phenix, before being
used as a search model for the native data set in Phaser80. Further model building and
refinement were done with this data set in Coot and Phenix. The final atomic model
had no Ramachandran torsion angle outliers and 98% of torsion angles in favored
positions. Crystallographic data are summarized in Table S2.
Fluorescence polarization. TASOR(106–332) was titrated into RNA-binding
buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 2 mM MgCl2, 0.5 mM TCEP) con-
taining 33 nM of a single-stranded RNA oligonucleotides 5′-labeled with 6-
carboxyfluorescein (6-FAM). Fluorescence polarization of 30-µl samples was
measured in 384-well black, clear-bottomed plates (Corning) with a ClarioSTAR
plate reader using 482/530 nm filters.
Differential scanning fluorimetry (DSF). 10 µL samples containing 10 µM pro-
tein (TASOR variants or PARP1 catalytic domain) in the presence or absence of
benzamide (Sigma) were loaded into glass capillaries (Nanotemper) by capillary
action. Intrinsic protein fluorescence at 330 nm and 350 nm was monitored
between 15 and 90 °C in the Prometheus NT.48 instrument (Nanotemper), and the
Tm values calculated within the accompanying software by taking the turning point
of the first derivative of the F350:F330 ratio as a function of temperature.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The NMR data were deposited in the Biological Magnetic Resonance Bank, data set ID
50094. The structure factors and atomic coordinates for the crystal structure were
deposited in the Protein Data Bank (PDB) with code 6TL1. The original experimental X-
ray diffraction images were deposited in the SBGrid Data Bank (data.SBGrid.org), with
Data ID 742. The CUT&RUN, ChIP and CUT&Tag data generated and analyzed here
have been deposited in the Gene Expression Omnibus (GEO) database under accession
codes GSE155693 and GSE95480. Source data are provided with this paper.
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